BioLife Solutions, Inc. (BLFS)
USD 24.98
(-7.03%)
USD 24.98
(-7.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 7.25 Million USD | -70.12% |
| 2022 | 24.27 Million USD | 156.46% |
| 2021 | -42.99 Million USD | 45.79% |
| 2020 | -79.3 Million USD | -1456.79% |
| 2019 | -5.09 Million USD | 83.38% |
| 2018 | -30.65 Million USD | -360.11% |
| 2017 | -6.66 Million USD | -563.35% |
| 2016 | 1.43 Million USD | 137.6% |
| 2015 | -3.82 Million USD | 61.52% |
| 2014 | -9.93 Million USD | -195.13% |
| 2013 | 10.44 Million USD | 0.39% |
| 2012 | 10.4 Million USD | 2.9% |
| 2011 | 10.11 Million USD | 12.0% |
| 2010 | 9.02 Million USD | 16.5% |
| 2009 | 7.75 Million USD | 56.13% |
| 2008 | 4.96 Million USD | 84.31% |
| 2007 | 2.69 Million USD | 3318.02% |
| 2006 | 78.8 Thousand USD | 92.99% |
| 2005 | 40.83 Thousand USD | 107.68% |
| 2004 | -531.68 Thousand USD | -545.4% |
| 2003 | -82.38 Thousand USD | -129.56% |
| 2002 | 278.7 Thousand USD | 197.41% |
| 2001 | -286.1 Thousand USD | 86.63% |
| 2000 | -2.13 Million USD | -1338.65% |
| 1999 | 172.7 Thousand USD | 2290.89% |
| 1998 | -7883.00 USD | -114.62% |
| 1997 | 53.91 Thousand USD | 103.05% |
| 1996 | -1.76 Million USD | -66.34% |
| 1995 | -1.06 Million USD | 55.68% |
| 1994 | -2.4 Million USD | -20.0% |
| 1993 | -2 Million USD | 13.04% |
| 1992 | -2.3 Million USD | 55.77% |
| 1991 | -5.2 Million USD | -126.09% |
| 1990 | -2.3 Million USD | -475.0% |
| 1989 | -400 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 13.91 Million USD | 24.08% |
| 2024 Q1 | 11.23 Million USD | 54.93% |
| 2023 Q1 | 24.11 Million USD | -0.65% |
| 2023 Q2 | 23.16 Million USD | -3.93% |
| 2023 FY | 7.25 Million USD | -70.12% |
| 2023 Q4 | 7.25 Million USD | -70.95% |
| 2023 Q3 | 24.96 Million USD | 7.77% |
| 2022 Q1 | -33.47 Million USD | 22.13% |
| 2022 Q3 | 16.8 Million USD | 806.31% |
| 2022 Q2 | 1.85 Million USD | 105.54% |
| 2022 FY | 24.27 Million USD | 156.46% |
| 2022 Q4 | 24.27 Million USD | 44.44% |
| 2021 FY | -42.99 Million USD | 45.79% |
| 2021 Q1 | -75.61 Million USD | 4.66% |
| 2021 Q2 | -46.77 Million USD | 38.14% |
| 2021 Q3 | -46.92 Million USD | -0.32% |
| 2021 Q4 | -42.99 Million USD | 8.39% |
| 2020 FY | -79.3 Million USD | -1456.79% |
| 2020 Q3 | -108.22 Million USD | -274.25% |
| 2020 Q1 | -5.24 Million USD | -2.91% |
| 2020 Q2 | -28.91 Million USD | -451.68% |
| 2020 Q4 | -79.3 Million USD | 26.73% |
| 2019 FY | -5.09 Million USD | 83.38% |
| 2019 Q2 | -18.12 Million USD | 39.93% |
| 2019 Q4 | -5.09 Million USD | 74.09% |
| 2019 Q3 | -19.66 Million USD | -8.49% |
| 2019 Q1 | -30.16 Million USD | 1.6% |
| 2018 FY | -30.65 Million USD | -360.11% |
| 2018 Q4 | -30.65 Million USD | 5.32% |
| 2018 Q3 | -32.38 Million USD | -128.57% |
| 2018 Q2 | -14.16 Million USD | -101.44% |
| 2018 Q1 | -7.03 Million USD | -5.55% |
| 2017 Q3 | -2.83 Million USD | -22.29% |
| 2017 FY | -6.66 Million USD | -563.35% |
| 2017 Q4 | -6.66 Million USD | -135.4% |
| 2017 Q2 | -2.31 Million USD | -240.48% |
| 2017 Q1 | 1.64 Million USD | 14.58% |
| 2016 Q1 | -1.66 Million USD | 56.53% |
| 2016 FY | 1.43 Million USD | 137.6% |
| 2016 Q3 | 381.82 Thousand USD | 157.71% |
| 2016 Q4 | 1.43 Million USD | 276.61% |
| 2016 Q2 | -661.66 Thousand USD | 60.2% |
| 2015 Q4 | -3.82 Million USD | -62.64% |
| 2015 Q2 | -3.89 Million USD | -31.11% |
| 2015 Q1 | -2.97 Million USD | 70.1% |
| 2015 FY | -3.82 Million USD | 61.52% |
| 2015 Q3 | -2.35 Million USD | 39.65% |
| 2014 Q1 | -12.83 Million USD | -222.9% |
| 2014 Q3 | -3.27 Million USD | 44.51% |
| 2014 Q2 | -5.9 Million USD | 54.03% |
| 2014 FY | -9.93 Million USD | -195.13% |
| 2014 Q4 | -9.93 Million USD | -203.46% |
| 2013 Q3 | 10.52 Million USD | -0.03% |
| 2013 Q1 | 10.54 Million USD | 1.3% |
| 2013 FY | 10.44 Million USD | 0.39% |
| 2013 Q4 | 10.44 Million USD | -0.73% |
| 2013 Q2 | 10.52 Million USD | -0.14% |
| 2012 FY | 10.4 Million USD | 2.9% |
| 2012 Q4 | 10.4 Million USD | -1.75% |
| 2012 Q3 | 10.59 Million USD | 1.42% |
| 2012 Q2 | 10.44 Million USD | 2.1% |
| 2012 Q1 | 10.22 Million USD | 1.15% |
| 2011 FY | 10.11 Million USD | 12.0% |
| 2011 Q1 | 9.34 Million USD | 3.49% |
| 2011 Q2 | 9.61 Million USD | 2.88% |
| 2011 Q3 | 9.88 Million USD | 2.8% |
| 2011 Q4 | 10.11 Million USD | 2.33% |
| 2010 Q1 | 8.13 Million USD | 4.97% |
| 2010 FY | 9.02 Million USD | 16.5% |
| 2010 Q3 | 8.73 Million USD | 3.75% |
| 2010 Q4 | 9.02 Million USD | 3.34% |
| 2010 Q2 | 8.42 Million USD | 3.52% |
| 2009 FY | 7.75 Million USD | 56.13% |
| 2009 Q1 | 6.03 Million USD | 21.56% |
| 2009 Q4 | 7.75 Million USD | 3.45% |
| 2009 Q2 | 6.87 Million USD | 13.95% |
| 2009 Q3 | 7.49 Million USD | 8.95% |
| 2008 Q4 | 4.96 Million USD | 13.39% |
| 2008 FY | 4.96 Million USD | 84.31% |
| 2008 Q2 | 3.87 Million USD | 16.49% |
| 2008 Q3 | 4.37 Million USD | 12.97% |
| 2008 Q1 | 3.32 Million USD | 23.52% |
| 2007 Q4 | 2.69 Million USD | 34.97% |
| 2007 Q1 | 461.32 Thousand USD | 485.41% |
| 2007 Q2 | 1.04 Million USD | 126.07% |
| 2007 Q3 | 1.99 Million USD | 91.35% |
| 2007 FY | 2.69 Million USD | 3318.02% |
| 2006 Q1 | 188.08 Thousand USD | 360.63% |
| 2006 Q4 | 78.8 Thousand USD | 128.31% |
| 2006 Q2 | -418.05 Thousand USD | -322.27% |
| 2006 FY | 78.8 Thousand USD | 92.99% |
| 2006 Q3 | -278.31 Thousand USD | 33.43% |
| 2005 FY | 40.83 Thousand USD | 107.68% |
| 2005 Q1 | -361.42 Thousand USD | 32.02% |
| 2005 Q2 | -189.39 Thousand USD | 47.6% |
| 2005 Q3 | -75.28 Thousand USD | 60.25% |
| 2005 Q4 | 40.83 Thousand USD | 154.23% |
| 2004 Q3 | -571.79 Thousand USD | 21.06% |
| 2004 FY | -531.68 Thousand USD | -545.4% |
| 2004 Q2 | -724.34 Thousand USD | 17.94% |
| 2004 Q4 | -531.68 Thousand USD | 7.01% |
| 2004 Q1 | -882.67 Thousand USD | -971.47% |
| 2003 Q3 | 734.97 Thousand USD | 3.44% |
| 2003 Q4 | -82.38 Thousand USD | -111.21% |
| 2003 Q2 | 710.53 Thousand USD | 114.52% |
| 2003 Q1 | 331.21 Thousand USD | 18.84% |
| 2003 FY | -82.38 Thousand USD | -129.56% |
| 2002 Q3 | 96.76 Thousand USD | 106.6% |
| 2002 Q4 | 278.7 Thousand USD | 188.02% |
| 2002 FY | 278.7 Thousand USD | 197.41% |
| 2002 Q1 | 128.65 Thousand USD | 144.97% |
| 2002 Q2 | -1.46 Million USD | -1239.91% |
| 2001 Q4 | -286.1 Thousand USD | 18.6% |
| 2001 FY | -286.1 Thousand USD | 86.63% |
| 2001 Q3 | -351.5 Thousand USD | -192.48% |
| 2001 Q2 | -120.18 Thousand USD | 88.86% |
| 2001 Q1 | -1.07 Million USD | 49.57% |
| 2000 Q2 | -4.22 Million USD | -773.72% |
| 2000 Q4 | -2.13 Million USD | 33.02% |
| 2000 FY | -2.13 Million USD | -1338.65% |
| 2000 Q3 | -3.19 Million USD | 24.46% |
| 2000 Q1 | 627.52 Thousand USD | 422.94% |
| 1999 Q3 | 130 Thousand USD | -13.33% |
| 1999 Q1 | 100 Thousand USD | 1368.55% |
| 1999 Q4 | 120 Thousand USD | -7.69% |
| 1999 Q2 | 150 Thousand USD | 50.0% |
| 1999 FY | 172.7 Thousand USD | 2290.89% |
| 1998 FY | -7883.00 USD | -114.62% |
| 1998 Q1 | 180 Thousand USD | 233.85% |
| 1998 Q2 | 50 Thousand USD | -72.22% |
| 1998 Q3 | 280 Thousand USD | 460.0% |
| 1998 Q4 | -7883.00 USD | -102.82% |
| 1997 Q4 | 53.91 Thousand USD | 138.51% |
| 1997 Q2 | -790 Thousand USD | 47.33% |
| 1997 Q1 | -1.5 Million USD | 0.0% |
| 1997 FY | 53.91 Thousand USD | 103.05% |
| 1997 Q3 | -140 Thousand USD | 82.28% |
| 1996 FY | -1.76 Million USD | -66.34% |
| 1996 Q1 | -1.3 Million USD | -85.71% |
| 1996 Q2 | -1.22 Million USD | 5.52% |
| 1996 Q3 | -2.5 Million USD | -103.55% |
| 1995 Q4 | -700 Thousand USD | 36.36% |
| 1995 Q1 | -500 Thousand USD | 0.0% |
| 1995 FY | -1.06 Million USD | 55.68% |
| 1995 Q2 | -1.06 Million USD | -112.73% |
| 1995 Q3 | -1.1 Million USD | -3.42% |
| 1994 Q2 | -2.4 Million USD | -140.0% |
| 1994 Q3 | -2.4 Million USD | 0.0% |
| 1994 Q1 | -1 Million USD | 37.5% |
| 1994 FY | -2.4 Million USD | -20.0% |
| 1993 Q4 | -1.6 Million USD | 36.0% |
| 1993 FY | -2 Million USD | 13.04% |
| 1993 Q3 | -2.5 Million USD | -25.0% |
| 1993 Q2 | -2 Million USD | -11.11% |
| 1993 Q1 | -1.8 Million USD | 0.0% |
| 1992 FY | -2.3 Million USD | 55.77% |
| 1992 Q3 | -1.2 Million USD | 47.83% |
| 1992 Q2 | -2.3 Million USD | 0.0% |
| 1992 Q4 | -1.8 Million USD | -50.0% |
| 1991 Q4 | -900 Thousand USD | 0.0% |
| 1991 FY | -5.2 Million USD | -126.09% |
| 1991 Q2 | -5.2 Million USD | 0.0% |
| 1990 Q3 | -2.7 Million USD | -17.39% |
| 1990 Q2 | -2.3 Million USD | 0.0% |
| 1990 FY | -2.3 Million USD | -475.0% |
| 1989 FY | -400 Thousand USD | 0.0% |
| 1989 Q2 | -400 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -181.015% |
| AngioDynamics, Inc. | -70.14 Million USD | 110.34% |
| AtriCure, Inc. | -9.81 Million USD | 173.89% |
| Avinger, Inc. | 10.12 Million USD | 28.33% |
| Azenta, Inc. | -618.47 Million USD | 101.173% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 99.704% |
| Daxor Corporation | 755.65 Thousand USD | -859.824% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 593.401% |
| Femasys Inc. | -15.01 Million USD | 148.304% |
| GlucoTrack, Inc. | -4.29 Million USD | 268.831% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 81.156% |
| Hologic, Inc. | 374.4 Million USD | 98.063% |
| ICU Medical, Inc. | 1.45 Billion USD | 99.5% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 100.273% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 203.068% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 240.182% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 269.168% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 269.168% |
| Masimo Corporation | 804 Million USD | 99.098% |
| Microbot Medical Inc. | -2.28 Million USD | 417.279% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 175.586% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 97.6% |
| Nephros, Inc. | -2.47 Million USD | 393.525% |
| NovoCure Limited | 355.42 Million USD | 97.959% |
| NEXGEL, Inc. | 98 Thousand USD | -7301.02% |
| NEXGEL, Inc. | 98 Thousand USD | -7301.02% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 87.718% |
| OraSure Technologies, Inc. | -276.9 Million USD | 102.619% |
| Pro-Dex, Inc. | 10.91 Million USD | 33.556% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 120.593% |
| Predictive Oncology Inc. | -5.87 Million USD | 223.522% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -139.437% |
| QuidelOrtho Corporation | 2.49 Billion USD | 99.709% |
| Repligen Corporation | -39.51 Million USD | 118.353% |
| Sanara MedTech Inc. | 6.64 Million USD | -9.151% |
| STAAR Surgical Company | -147.2 Million USD | 104.927% |
| Sharps Technology, Inc. | -3.01 Million USD | 340.731% |
| Utah Medical Products, Inc. | -92.52 Million USD | 107.839% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 99.631% |
| Jin Medical International Ltd. | -2.81 Million USD | 357.517% |